Together, we can transform the future of cancer care.
Tracking early stage breast cancer with ultrasensitive ctDNA
Information for patients with breast cancer
Monitoring therapy response with ultrasensitive ctDNA across cancer types
Ultrasensitive ctDNA detection in early-stage lung cancer
Personalis is transforming the development of next-generation therapies.
Friday, MAY 29, 2020 | Online
Title: Exome scale liquid biopsy characterization of putative neoantigens and genomic biomarkers pre- and post anti-PD-1 therapy in squamous cell carcinoma of the head and neck. Session Title: Head and Neck Cancer Location: Online Abstract Number: 6557 Presenter: Charles Abbott
View Poster
Title: Validation of an exome and transcriptome based diagnostic platform enabling clinical cancer therapy selection and emerging composite biomarkers for immunotherapy. Location: Online Abstract Number: e15583 Presenter: Sebastian Saldivar
View e-Abstract
